Citation Impact
Citing Papers
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin P-domain
2002 StandoutNobel
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
2020 StandoutScienceNobel
IMF-κB and Rel: Participants in a Multiform Transcriptional Regulatory System
1993
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
Study of the Interaction of HIV-1 and HIV-2 Envelope Glycoproteins with the CD4 Receptor and Role of N-Glycans
1992 StandoutNobel
Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus
1991
ASSOCIATION BETWEEN BIOLOGICAL PROPERTIES OF HUMAN IMMUNODEFICIENCY VIRUS VARIANTS AND RISK FOR AIDS AND AIDS MORTALITY
1989
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations
1989
Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection
1991
Chemokines and HIV–1 second receptors
1996
Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1
1994
Unwelcomed Guests with Master Keys: How HIV Uses Chemokine Receptors for Cellular Entry
1997
DC-SIGN
2000 StandoutNobel
Distinctive pattern of infection and replication of HIV1 strains in blood-derived macrophages
1992
Viral Phenotype and Immune Response in Primary Human Immunodeficiency Virus Type 1 Infection
1992
Chemokine Receptor Regulation and HIV Type 1 Tropism in Monocyte-Macrophages
1998
Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp!20 gene
1991 Nature
Analyzing real-time PCR data by the comparative CT method
2008 Standout
Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis
1991
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
1998 StandoutNobel
Natural controlled HIV infection: Preserved HIV-specific immunity despite undetectable replication competent virus
2005
A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors
1996 Standout
CD4: Collaborator in immune recognition and HIV infection
1990 StandoutNobel
The Immunopathogenesis of Human Immunodeficiency Virus Infection
1993
mRNA vaccines manufacturing: Challenges and bottlenecks
2021
Antibody-independent, complement-mediated enhancement of HIV-1 infection by mannosidase I and II inhibitors
1989
HIV-1 V3 domain variation in brain and spleen of children with AIDS: Tissue-specific evolution within host-determined quasispecies
1991
Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages.
1992
A concise enantioselective synthesis of iminosugar derivatives
2006
A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site
1990
Crystal structure of an HIV-binding recombinant fragment of human CD4
1990 StandoutNatureNobel
Human Immunodeficiency Virus Type 1 Quasispecies In Vivo and Ex Vivo
1992
NONO Detects the Nuclear HIV Capsid to Promote cGAS-Mediated Innate Immune Activation
2018
Infection and Apoptotic Cell Death of CD4 + T Cells during an Immune Response to HIV-1-Pulsed Dendritic Cells
1994 StandoutNobel
Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors
2004
Immunopathogenic Mechanisms in Human Immunodeficiency Virus (HIV) Infection
1991
The Role of the CD28 Receptor During T Cell Responses to Antigen
1993
High Titers of Cytopathic Virus in Plasma of Patients with Symptomatic Primary HIV-1 Infection
1991
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
1997 StandoutNatureNobel
Regulation by HIV Rev depends upon recognition of splice sites
1989 StandoutNobel
Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI
1991 StandoutNobel
Membrane Expression of HIV Envelope Glycoproteins Triggers Apoptosis in CD4 Cells
1993
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
RNA Virus Populations as Quasispecies
1992
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
2001 Standout
Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates
1988
Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope
1994
Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1
1990
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines.
1989
Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120
1991
Anti-retroviral therapy of human immunodeficiency virus infection: current strategies and challenges for the future [published erratum appears in Blood 1991 Dec 15;78(12):3330]
1991
Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture
1991
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
Molecular Targets for AIDS Therapy
1990 Science
Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation
1992
Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation
1990
Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population
1992
Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates
1995
Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection
1993 Science
Protein Glucosylation and Its Role in Protein Folding
2000
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element
1991
A novel mode of human immunodeficiency virus type 1 (HIV-1) activation: ligation of CD28 alone induces HIV-1 replication in naturally infected lymphocytes
1993
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
1994 StandoutNobel
Differential susceptibility of naive and memory CD4+ T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI
1997
Human Immunodeficiency Virus Type 1 T-Lymphotropic Strains Enter Macrophages via a CD4- and CXCR4-Mediated Pathway: Replication Is Restricted at a Postentry Level
1998
Fc receptors in antibody‐dependent enhancement of viral infections
2015
Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry
1997
Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein
1997 StandoutNobel
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys
1991
Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates
1994
Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera
1995
HIV-1 Selection by Epidermal Dendritic Cells during Transmission across Human Skin
1998
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees
1990
Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160
1993 StandoutNobel
Expression of CCR5 Increases during Monocyte Differentiation and Directly Mediates Macrophage Susceptibility to Infection by Human Immunodeficiency Virus Type 1
1998
Cell surface receptors, virus entry and tropism of primate lentiviruses
2002
Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
1997 StandoutNobel
Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.
1992
Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates
1990
Pathogenesis of human immunodeficiency virus infection
1993
Catalytic asymmetric synthesis of a functionalized indolizidine derivative. A useful intermediate suitable for the synthesis of various glycosidase inhibitors
1993
Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy
1995
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1
1997
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections.
1994 StandoutNobel
Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages.
1995
Replication of HIV-1 in Dendritic Cell-Derived Syncytia at the Mucosal Surface of the Adenoid
1996 StandoutScienceNobel
Quantitation of Viral Load Using Real-Time Amplification Techniques
2001
Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression
1994
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage
1998 StandoutNobel
Programmed Death of T Cells in HIV-1 Infection
1992 Science
The Susceptibility to X4 and R5 Human Immunodeficiency Virus-1 Strains of Dendritic Cells Derived In Vitro From CD34+ Hematopoietic Progenitor Cells Is Primarily Determined by Their Maturation Stage
1999
High Levels of HIV-1 in Plasma During All Stages of Infection Determined By Competitive PCR
1993 Science
Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro
1991
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
2000
Rapid Infection of Oral Mucosal-Associated Lymphoid Tissue with Simian Immunodeficiency Virus
1999 StandoutScienceNobel
Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes
1991
A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.
1993 StandoutNobel
Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus
1992
Containment of Simian Immunodeficiency Virus Infection in Vaccinated Macaques: Correlation with the Magnitude of Virus-Specific Pre- and Postchallenge CD4+ and CD8+ T Cell Responses
2002
Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
1989 StandoutNobel
HIV replication in CD4+T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines
1996 StandoutNobel
Mechanism by which the lectin actinohivin blocks HIV infection of target cells
2009 StandoutNobel
Inhibitors of human immunodeficiency virus integrase.
1993 StandoutNobel
HIV VACCINES
2005
Prohormone processing in Xenopus oocytes: characterization of cleavage signals and cleavage enzymes.
1991 StandoutNobel
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
In Vivo Distribution of the Human Immunodeficiency Virus/Simian Immunodeficiency Virus Coreceptors: CXCR4, CCR3, and CCR5
1998
Enhancement of Antitumor Immunity by CTLA-4 Blockade
1996 StandoutScienceNobel
Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.
1989
Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160
1989
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Activity-Based Profiling of Proteases
2014
Determinants of Human Immunodeficiency Virus Type 1 Escape from the Primary CD8+ Cytotoxic T Lymphocyte Response
2004
Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization
1990
Asymmetric Enamine Catalysis
2007 StandoutNobel
Apoptosis in AIDS
1993 StandoutScienceNobel
Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B.
1996 StandoutNobel
Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160
1992 StandoutNobel
Cyclic Carbopalladation. A Versatile Synthetic Methodology for the Construction of Cyclic Organic Compounds
1996 StandoutNobel
NMR structure of the calreticulin P-domain
2001 StandoutNobel
Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization
1994
LAV Revisited: Origins of the Early HIV-1 Isolates from Institut Pasteur
1991 StandoutScienceNobel
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains
1997
Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism
1992
Chemical Glycoproteomics
2016 StandoutNobel
Identification of the Envelope V3 Loop as the Primary Determinant of Cell Tropism in HIV-1
1991 Science
Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1
1994 StandoutNobel
Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals
1993
Works of Rob A. Gruters being referenced
The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals
2013
Blood Monocytes Infected In Vivo by HIV-1 Variants with a Syncytium-Inducing Phenotype
1994
Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase
1987 Nature
Vaccination with Rev and Tat against AIDS
1999
Development of a real-time quantitative RT-PCR for the detection of HIV-2 RNA in plasma
2000
Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men.
1990
Biomedical application of MALDI mass spectrometry for small‐molecule analysis
2010
Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.
1997
Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes
2002
Immunological and virological markers in individuals progressing from seroconversion to AIDS
1991
Vaccine-induced enhancement of viral infections
2008
Early Replication Steps but Not Cell Type-Specific Signalling of the Viral Long Terminal Repeat Determine HIV-1 Monocytotropism
1993
Selective loss of T cell functions in different stages of HIV infection Early loss ofanti‐CD3‐induced T cell proliferation followed by decreased anti‐CD3‐induced cytotoxic T lymphocyte generation in AIDS‐related complex and AIDS
1990
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection
2018
Non‐mitogenic T cell activation signals are sufficient for induction of human immunodeficiency virus transcription
1991
Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24
1989
Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates
1989
Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual
1991
Kinetics of Antiviral Activity by Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes (CTL) and Rapid Selection of CTL Escape Virus In Vitro
1998
Coreceptor Usage of Human Immunodeficiency Virus Type 2 Primary Isolates and Biological Clones Is Broad and Does Not Correlate with Their Syncytium-Inducing Capacities
1998
Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex
1988